WallStSmart

Medline Inc. Class A Common Stock (MDLN)vsPrologis Inc (PLD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 209% more annual revenue ($28.43B vs $9.19B). PLD leads profitability with a 36.2% profit margin vs 4.1%. MDLN trades at a lower P/E of 29.9x. PLD earns a higher WallStSmart Score of 55/100 (C).

MDLN

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 5.0Value: 8.3Quality: 7.8
Piotroski: 4/9

PLD

Buy

55

out of 100

Grade: C

Growth: 6.0Profit: 7.0Value: 4.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDLNUndervalued (+32.7%)

Margin of Safety

+32.7%

Fair Value

$66.92

Current Price

$42.67

$24.25 discount

UndervaluedFair: $66.92Overvalued
PLDSignificantly Overvalued (-116.9%)

Margin of Safety

-116.9%

Fair Value

$60.09

Current Price

$130.36

$70.27 premium

UndervaluedFair: $60.09Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLN0 strengths · Avg: 0/10

No standout strengths identified

PLD4 strengths · Avg: 9.3/10
Profit MarginProfitability
36.2%10/10

Keeps 36 of every $100 in revenue as profit

Operating MarginProfitability
41.3%10/10

Strong operational efficiency at 41.3%

Market CapQuality
$121.52B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Areas to Watch

MDLN4 concerns · Avg: 3.0/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Free Cash FlowQuality
$-113.00M2/10

Negative free cash flow — burning cash

PLD4 concerns · Avg: 3.3/10
P/E RatioValuation
36.6x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
4.0%4/10

4.0% revenue growth

Return on EquityProfitability
6.1%3/10

ROE of 6.1% — below average capital efficiency

PEG RatioValuation
99.932/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLN

Revenue growth of 14.8% demonstrates continued momentum.

Bull Case : PLD

The strongest argument for PLD centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 36.2% and operating margin at 41.3%.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.

Bear Case : PLD

The primary concerns for PLD are P/E Ratio, Revenue Growth, Return on Equity.

Key Dynamics to Monitor

MDLN is growing revenue faster at 14.8% — sustainability is the question.

MDLN generates stronger free cash flow (-113M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PLD scores higher overall (55/100 vs 52/100), backed by strong 36.2% margins. MDLN offers better value entry with a 32.7% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Prologis Inc

REAL ESTATE · REIT - INDUSTRIAL · USA

Prologis, Inc. is a real estate investment trust headquartered in San Francisco, California that invests in logistics facilities, with a focus on the consumption side of the global supply chain.

Want to dig deeper into these stocks?